Education
About Us
Working with TipRanks
Follow Us
Sanuwave Health (SNWV)
NASDAQ:SNWV
SNWV Stock Chart & Stats
$31.30
$1.30(5.42%)
At close: 4:00 PM EST
$31.30
$1.30(5.42%)
Day’s Range― - ―
52-Week Range$23.55 - $46.59
Previous CloseN/A
Volume17.14K
Average Volume (3M)78.76K
Market Cap
$228.47M
Enterprise Value$239.12M
Total Cash (Recent Filing)$9.60M
Total Debt (Recent Filing)$24.45M
Price to Earnings (P/E)―
Beta0.73
Next Earnings
Apr 07, 2026EPS Estimate
0.17Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.46
Shares Outstanding8,576,164
10 Day Avg. Volume75,518
30 Day Avg. Volume78,757
Financial Highlights & Ratios
PEG Ratio0.08
Price to Book (P/B)-8.07
Price to Sales (P/S)3.15
P/FCF Ratio52.24
Enterprise Value/Market Cap1.05
Enterprise Value/Revenue5.79
Enterprise Value/Gross Profit7.45
Enterprise Value/Ebitda100.68
Forecast
1Y Price Target
$54.00Price Target Upside72.52% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue GrowthRecord quarterly revenue indicates strong market presence and potential for sustained growth, enhancing long-term business prospects.
Strategic PartnershipsThe partnership with Healogics expands market reach, potentially increasing sales and strengthening Sanuwave's position in wound care.
Financial PositionThe refinancing reduces interest rates and debt load, improving cash flow and financial stability, supporting long-term operations.
Bears Say
High LeverageHigh leverage poses financial risk, limiting flexibility and increasing vulnerability to economic downturns, impacting long-term stability.
Profitability ChallengesPersistent profitability issues highlight challenges in managing expenses, which could hinder sustainable growth and investor confidence.
Leadership InstabilityLeadership changes can disrupt strategic direction and execution, affecting operational efficiency and long-term business continuity.
Sanuwave Health News
SNWV FAQ
What was Sanuwave Health’s price range in the past 12 months?
Sanuwave Health lowest stock price was $23.55 and its highest was $46.59 in the past 12 months.
What is Sanuwave Health’s market cap?
Sanuwave Health’s market cap is $228.47M.
When is Sanuwave Health’s upcoming earnings report date?
Sanuwave Health’s upcoming earnings report date is Apr 07, 2026 which is in 62 days.
How were Sanuwave Health’s earnings last quarter?
Sanuwave Health released its earnings results on Nov 07, 2025. The company reported $0.46 earnings per share for the quarter, beating the consensus estimate of $0.32 by $0.14.
Is Sanuwave Health overvalued?
According to Wall Street analysts Sanuwave Health’s price is currently Undervalued.
Does Sanuwave Health pay dividends?
Sanuwave Health does not currently pay dividends.
What is Sanuwave Health’s EPS estimate?
Sanuwave Health’s EPS estimate is 0.17.
How many shares outstanding does Sanuwave Health have?
Sanuwave Health has 8,576,164 shares outstanding.
What happened to Sanuwave Health’s price movement after its last earnings report?
Sanuwave Health reported an EPS of $0.46 in its last earnings report, beating expectations of $0.32. Following the earnings report the stock price went up 17.683%.
Which hedge fund is a major shareholder of Sanuwave Health?
Currently, no hedge funds are holding shares in SNWV
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Sanuwave Health Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$54.00 (72.52% Upside)
$54.00 (72.52% Upside)
Blogger Sentiment
Bullish
SNWV Sentiment 70%
Sector Average 69%
Sector Average 69%
Insider Transactions
Sold Shares
Worth $5.0M over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
32.00%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
62.97%
Trailing 12-Months
Company Description
Sanuwave Health
SANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company's lead regenerative product is the dermaPACE device for treating diabetic foot ulcers. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, which helps to restore the body's normal healing processes and regeneration. The company also focuses on applying its Pulsed Acoustic Cellular Expression technology in wound healing, orthopedic, plastic/cosmetic, and cardiac conditions. In addition, it offers UltraMIST, non-contact and non-thermal ultrasound therapy device used to treat diabetic foot ulcers, pressure ulcers, venous leg ulcers, deep tissue pressure injuries, and surgical wounds; and orthoPACE system to treat tendinopathies and acute and nonunion fractures. The company was founded in 2005 and is headquartered in Suwanee, Georgia.
SNWV Company Deck
SNWV Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
SANUWAVE achieved record-breaking quarterly revenue and significant system sales, indicating strong growth and market presence. However, the company faced challenges in meeting its revenue guidance due to market uncertainty and disruption. Despite these challenges, the outlook for reimbursement changes is positive, and September showed strong performance, suggesting potential future growth.View all SNWV earnings summariesSNWV Stock 12 Month Forecast
Average Price Target
$54.00
▲(72.52% Upside)
Technical Analysis
Cerus
―
Senseonics Holdings
―
Tactile Systems Technology
―
Viemed Healthcare
―
Brainsway
―
Ownership Overview
27.60% Insiders
7.14% Mutual Funds
0.45% Other Institutional Investors
56.87% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---